Scalp flaking seems harmless and picking the scabs can even be satisfying for many. However, it may signal more serious ...

Psoriasis is a chronic, recurrent, and incurable autoimmune disease in which the body mistakenly attacks its own tissue, ...

Researchers have uncovered a previously unrecognized role for immune cell surface sugars in driving inflammation in psoriasis. Scientists have refined how they understand the role of sugars called ...

Psoriasis is a chronic, immune-mediated skin condition. It causes red, scaly, itchy, often inflamed patches. Because the underlying issue involves immune response and skin-cell overproduction, there’s ...

Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the treatment of plaque psoriasis. We conducted a phase 3, double-blind, randomized, ...

When psoriasis develops on the scalp, hair loss sometimes follows. While hair tends to regrow once the scalp psoriasis clears, there are things you can do right now to prevent further hair loss. 1.

If you have psoriasis on your scalp, it can cause redness, thick scales or patches, itching, and even pain. It can also cause temporary hair loss. It’s similar to psoriasis on other parts of the body, ...

Guselkumab demonstrated strong efficacy in treating moderate to severe scalp psoriasis, especially in individuals with skin of color, achieving nearly 70% complete scalp clearance by week 48. The ...

KUTV — Plaque psoriasis is a chronic, inflammatory skin disease that affects many people. Symptoms, which include itch, scaling, redness, and flaking, can have a significant negative impact on ...

In the VISIBLE trial, guselkumab led to significant and sustained improvements in scalp psoriasis severity and quality of life in patients with skin of color through 48 weeks. Researchers evaluated ...

Once-daily roflumilast foam, 0.3% (Zoryve) significantly improved scalp and body symptoms of plaque psoriasis in a phase III trial. Improvements in scalp itch were also greater for patients randomized ...